Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
52 hedge funds and large institutions have $67.1M invested in Marrone Bio Innovations, Inc. in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
21% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 14
6% more funds holding
Funds holding: 49 → 52 (+3)
2% less capital invested
Capital invested by funds: $68.5M → $67.1M (-$1.45M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$2.06M |
| 2 |
Goldman Sachs
New York
|
+$349K |
| 3 |
Millennium Management
New York
|
+$176K |
| 4 |
FC
Fairpointe Capital
Chicago,
Illinois
|
+$176K |
| 5 |
BlackRock
New York
|
+$137K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$184K |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$81.1K |
| 3 |
SG Americas Securities
New York
|
-$59K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$40.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$27K |
MBII Hedge Fund Activity: Q3 2019 in Review
52 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q3 2019, worth a combined $67.1M — down 2.1% from $68.5M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new MBII positions and 2 closed out — a net gain of 3 holders — while 17 added to existing stakes and 14 trimmed.
The largest buyer was Ardsley Advisory Partners, adding an estimated $2.06M. The largest seller was Primecap Management, cutting an estimated $184K.
- 52 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q3 2019, up from 49 in Q2 2019.
- Funds reported $67.1M of Marrone Bio Innovations, Inc. stock for Q3 2019, down 2.1% quarter-over-quarter.
- 5 funds opened new Marrone Bio Innovations, Inc. positions in Q3 2019 and 2 closed out, a net change of +3 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q3 2019 was Ardsley Advisory Partners, an estimated $2.06M added.
- The largest Marrone Bio Innovations, Inc. seller in Q3 2019 was Primecap Management, an estimated $184K sold.
Based on aggregated 13F filings for Q3 2019.